153 related articles for article (PubMed ID: 34695415)
21. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
[TBL] [Abstract][Full Text] [Related]
22. Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.
Wu AH; Yang DY; Liu YD; Chen X; Chen XL; Lu S; Chen SL
Curr Med Sci; 2018 Jun; 38(3):505-512. PubMed ID: 30074219
[TBL] [Abstract][Full Text] [Related]
23. TETology: Epigenetic Mastermind in Action.
Seethy A; Pethusamy K; Chattopadhyay I; Sah R; Chopra A; Dhar R; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1701-1726. PubMed ID: 33694104
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
Pronier E; Almire C; Mokrani H; Vasanthakumar A; Simon A; da Costa Reis Monte Mor B; Massé A; Le Couédic JP; Pendino F; Carbonne B; Larghero J; Ravanat JL; Casadevall N; Bernard OA; Droin N; Solary E; Godley LA; Vainchenker W; Plo I; Delhommeau F
Blood; 2011 Sep; 118(9):2551-5. PubMed ID: 21734233
[TBL] [Abstract][Full Text] [Related]
25. Targeting SIRT4/TET2 Signaling Alleviates Human Keratinocyte Senescence by Reducing 5-hydroxymethylcytosine Loss.
Yi Y; Wang Y; Wu Y; Liu Y
Lab Invest; 2024 Feb; 104(2):100268. PubMed ID: 37898292
[TBL] [Abstract][Full Text] [Related]
26. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract][Full Text] [Related]
27. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
[TBL] [Abstract][Full Text] [Related]
28. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.
Shi X; Yu Y; Luo M; Zhang Z; Shi S; Feng X; Chen Z; He J
PLoS One; 2016; 11(4):e0153100. PubMed ID: 27050164
[TBL] [Abstract][Full Text] [Related]
29. Ten-Eleven Translocation Genes are Downregulated in Endometriosis.
Roca FJ; Loomans HA; Wittman AT; Creighton CJ; Hawkins SM
Curr Mol Med; 2016; 16(3):288-98. PubMed ID: 26917261
[TBL] [Abstract][Full Text] [Related]
30. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
31. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.
Ichiyama K; Chen T; Wang X; Yan X; Kim BS; Tanaka S; Ndiaye-Lobry D; Deng Y; Zou Y; Zheng P; Tian Q; Aifantis I; Wei L; Dong C
Immunity; 2015 Apr; 42(4):613-26. PubMed ID: 25862091
[TBL] [Abstract][Full Text] [Related]
32. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
Shen Q; Zhang Q; Shi Y; Shi Q; Jiang Y; Gu Y; Li Z; Li X; Zhao K; Wang C; Li N; Cao X
Nature; 2018 Feb; 554(7690):123-127. PubMed ID: 29364877
[TBL] [Abstract][Full Text] [Related]
33. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
34. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
35. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Yang H; Liu Y; Bai F; Zhang JY; Ma SH; Liu J; Xu ZD; Zhu HG; Ling ZQ; Ye D; Guan KL; Xiong Y
Oncogene; 2013 Jan; 32(5):663-9. PubMed ID: 22391558
[TBL] [Abstract][Full Text] [Related]
36. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
37. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
[TBL] [Abstract][Full Text] [Related]
38. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
39. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
[TBL] [Abstract][Full Text] [Related]
40. Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
Jäwert F; Hasséus B; Kjeller G; Magnusson B; Sand L; Larsson L
Anticancer Res; 2013 Oct; 33(10):4325-8. PubMed ID: 24122999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]